# Mepolizumab

## Nucala 100mg inj

| 藥物代碼           | INUC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | severe refractory eosinophilic asthma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 副作用             | >10%:Central nervous system: Headache (19%)Local: Injection site reaction (8% to 15%)1% to 10%:Central nervous system: Fatigue (5%)Dermatologic: Eczema (3%), pruritus (3%)Gastrointestinal: Upper abdominal pain (3%)Genitourinary: Urinary tract infection (3%)Hypersensitivity: Hypersensitivity reaction (eosinophilic granulomatosis: 4%), angioedema (eosinophilic granulamatosis: 1%)Immunologic: Immunogenicity (asthma: 6%, eosinophilic granulomatosis: <2%; neutralizing: <1%)Infection: Influenza (3%)Neuromuscular & skeletal: Back pain (5%), muscle spasm (3%)Frequency not defined:Hypersensitivity: Delayed hypersensitivityInfection: Herpes zoster |
| 禁忌               | Hypersensitivity to mepolizumab or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 藥物保存方式       | 2-8度C,勿冷凍                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 用法用量           | Asthma: SC 100 mg once every 4 weeks                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 孕期用藥建議       | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 注射劑給藥建議途徑 | SC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 乾粉稀釋液         | 1.2 毫升的無菌注射用水                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 注意事項           | 1.建議使用 1.2 毫升的無菌注射用水泡製，最好使用 2 或 3 毫升的針筒與 21 號針頭。勿與其他藥物混合使用。 2.請以轉圈的方式輕輕轉動小瓶直到粉末溶解為止。勿用力振搖泡製的溶液，可能會引發泡沫或沉澱。 3.泡製後存放於 30°C 以下，勿冷凍， 8 小時內使用，否則應丟棄。                                                                                                                                                                                                                                                                                                                                                                                                        |

